« Back to Members

Ginsana SA, trading as SFI Switzerland

Ginsana SA, trading as SFI Switzerland

Ginsana SA, trading as SFI Switzerland (SFI)

Ginsana SA, trading as SFI Switzerland, offers an attractive combination of pharma and nutraceutical expertise with more than 70 years of existence and international success.

Since 2013, Ginsana SA is part of Soho Flordis International (SFI) Group. The core competences vary from distributing the branded line of nature-based, scientifically proven medicinal products (Ginsana, Gincosan, Songha Night, Pronatal , Prostatonin, KeenMind, Calorease) in more than 35 countries worldwide, to contract manufacturing for well-established pharmaceutical companies in EMEA, America and Far East. In 2015 SFI acquired a UK based company, Potter’s Herbal along with two new branded line of products: the Potter's and the Equazen range. In the same year Prothera Ltd, in Reno, Nevada has been acquired along with the line of Klaire Labs Products.
Ginsana SA and SFI are competent partners for R+D, medicine, drug and regulatory affairs, manufacturing, packaging, worldwide supply chain, logistics and analytical services. Their know-how encompasses the entire range of the business process, ensuring you expert handling at every stage from research and development to product distribution.
The sound scientific background of all the products, including but not limited to clinical and preclinical trials, is a guarantee of quality, safety and efficacy for doctors, pharmacists and patients all over the world and the base for the current and future success. For more information please visit www.sfihealth.com

Via Mulini
6934 Bioggio
T.: +41 91 610 31 11
F.: +41 91 610 32 09
http://www.sfihealth.com
info@ginsana.ch
sabrina.consonni@sfihealth.com
Contact name: Sabrina Consonni

  • Main activities
    Licensing-In
    Licensing-Out
    Co-development
    Trading
    Drug Product CMO

  • Drug stages
    Pre-clinical
    Phase I - Phase III
    Registration
    Market
    Life cycle management

  • Therapeutic areas
    Cancer supportive therapy
    Cardiology
    Cardiovascular
    CNS
    Diabetes
    Gastrointestinal
    Gynaecology
    Metabolism
    Respiratory
    Other

  • Markets
    CH
    EU Top 5
    Rest of Europe
    USA and Canada
    LATAM
    MENA
    BRICS
    ASEAN
    Africa
    Australia
    China
    India
    Korea
    Other

  • Drug product forms
    Oral (solid)
    Oral (liquid)
    Other

  • Other activities (non pharma)
    Analytical Services
    Distribution
    Medical Devices
    Medical Food
    Natural Products
    Nutraceuticals
    Pre-formulation

  • Other CMO activities
    Analytical Services
    Co-development
    Pre-formulation